ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AWKNF Awakn Life Sciences Corporation (QB)

0.0837
-0.0163 (-16.30%)
Jun 13 2024 - Closed
Delayed by 15 minutes

Awakn Life Sciences (QB) Financial Summary

The current AWKNF market cap is 2.93M. The company's latest EPS is CAD -0.2609 and P/E is -0.31.

Year End January 30 2023 20222023
CAD ($)CAD ($)
Total Revenue 246k1.5M
Operating Income -9.78M-9.19M
Net Income -15.95M-9.14M
Year End January 30 2023 20222023
CAD ($)CAD ($)
Total Assets 6.88M4.39M
Total Liabilities 3.85M4.44M
Total Equity 3.02M-49k

Cash Flow

Year End January 30 2023 20222023
CAD ($)CAD ($)
Operating -8.59M-7.36M
Investing -1.69M-95k
Financing 11.5M6.4M
Market Cap 2.93M
Price to Earnings Ratio -0.31
Price to Sales Ratio 1.87
Price to Cash Ratio 5.1
Price to Book Ratio -57.21
Dividend Yield -

Share Statistics

Shares Outstanding 35.04M
Average Volume (1 week) 5.56k
Average Volume (1 Month) 5.24k
52 Week Change -60.14%
52 Week High 0.26
52 Week Low 0.0422
Spread (Intraday) 0.1 (57.94%)

Company Info

Company Name Awakn Life Sciences Corporation (QB)
Address 301‐217 queen street w
toronto, ontario M5V 0R2
Website https://www.awaknlifesciences.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock